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Abstract
Objective: To analyze clinical and radiological findings that influence the pathological diagnosis of solitary 
pulmonary nodule (SPN) and to compare/validate two probabilistic models for predicting SPN malignancy in 
patients with SPN in Brazil. Methods: This was a retrospective study involving 110 patients diagnosed with SPN 
and submitted to resection of SPN at a tertiary hospital between 2000 and 2009. The clinical characteristics 
studied were gender, age, presence of systemic comorbidities, history of malignancy prior to the diagnosis of 
SPN, histopathological diagnosis of SPN, smoking status, smoking history, and time since smoking cessation. 
The radiological characteristics studied, in relation to the SPN, were presence of spiculated margins, maximum 
transverse diameter, and anatomical location. Two mathematical models, created in 1997 and 2007, respectively, 
were used in order to determine the probability of SPN malignancy. Results: We found that SPN malignancy 
was significantly associated with age (p = 0.006; OR = 5.70 for age > 70 years), spiculated margins (p = 0.001), 
and maximum diameter of SPN (p = 0.001; OR = 2.62 for diameters > 20 mm). The probabilistic model created 
in 1997 proved to be superior to that created in 2007—area under the ROC curve, 0.79 ± 0.44 (95% CI: 
0.70-0.88) vs. 0.69 ± 0.50 (95% CI: 0.59-0.79). Conclusions: Advanced age, greater maximum SPN diameter, 
and spiculated margins were significantly associated with the diagnosis of SPN malignancy. Our analysis shows 
that, although both mathematical models were effective in determining SPN malignancy in our population, 
the 1997 model was superior.
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Resumo
Objetivo: Analisar características clínicas e radiográficas que influenciaram o diagnóstico anatomopatológico 
de nódulo pulmonar solitário (NPS) e comparar/validar dois modelos probabilísticos de malignidade do NPS 
em pacientes com NPS no Brasil. Métodos: Análise retrospectiva de 110 pacientes com diagnóstico de NPS 
submetidos à ressecção em um hospital terciário no período entre 2000 e 2009. As características clínicas 
estudadas foram gênero, idade, presença de comorbidades sistêmicas, história de neoplasia maligna ao diagnóstico 
de NPS, diagnóstico histopatológico do NPS, tabagismo, carga tabágica e tempo de cessação do tabagismo. As 
características radiográficas avaliadas em relação ao NPS foram presença de margens espiculadas, tamanho do 
maior diâmetro transversal e localização anatômica do NPS. Foram utilizados dois modelos matemáticos, criados 
em 1997 e 2007, respectivamente, para determinar a probabilidade de malignidade do NPS. Resultados: Houve 
associações significantes entre malignidade do NPS e idade (p = 0,006; OR = 5,70 para idade >70 anos), presença 
de margens espiculadas (p = 0,001) e diâmetro maior do NPS (p = 0,001; OR = 2,62 para diâmetro >20 mm). 
O modelo probabilístico de 1997 mostrou-se superior ao de 2007 — área sob a curva [ASC] ROC = 0,79 ± 0,44 
(IC95%: 0,70-0,88) vs. ASC = 0,69 ± 0,50 (IC95%: 0,59-0,79). Conclusões: Idade elevada, maior diâmetro do 
NPS e presença de margens espiculadas tiveram associações significantes ao diagnóstico de malignidade do 
NPS. Nossa análise mostrou que, embora os dois modelos matemáticos sejam eficazes na determinação de 
malignidade do NPS nessa população, o modelo de 1997 mostrou-se superior.
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Methods
This was a retrospective study involving all 
of the patients submitted to resection of SPN at 
the Hospital São Paulo, located in the city of São 
Paulo, Brazil, between 2000 and 2009. The study 
was based on data from medical charts. We studied 
the following variables: gender; age; presence 
of systemic comorbidities; history of malignancy 
prior to the diagnosis of SPN; histopathological 
diagnosis of SPN (malignant disease vs. benign 
disease); smoking status (current smokers and 
former smokers); smoking history (in pack-years); 
and number of years since smoking cessation. 
In addition, we studied CT features of SPNs, 
including presence of spiculated margins, maximum 
transverse diameter (in mm), and anatomical 
location, as described in CT reports.
After data collection, we used the following 
inclusion criteria: having a confirmed diagnosis 
of SPN; having undergone surgical resection of 
SPN; having a medical chart containing the data 
needed for the analysis; and having a pathological 
diagnosis of SPN.
Of the 127 patients who were initially 
screened for inclusion in the study, 110 met 
the aforementioned criteria. The main reason 
for exclusion was having an incomplete medical 
chart, followed by having been diagnosed with 
multiple pulmonary nodules.
We determined the probability of SPN 
malignancy by using the mathematical models 
developed in the aforementioned studies and 
applying the equations defined by the authors.
Equations developed by Swensen et al.(3):
Probability of malignancy = ex/(1+ ex) (1)
x = −6.8272 + (0.0391 × age) +  
+ (0.7917 × smoke) + 
+ (1.3388 × cancer) +  
+ (0.1274 × diameter) +  
+ (1.0407 × spiculation) +  
+(0.7838 × location)  
(2)
where age is the age of the patient in years; 
smoke = 1 if the patient is a current or former 
smoker (otherwise, smoke = 0); cancer = 1 if 
the patient has a history of an extrathoracic 
cancer that was diagnosed more than five years 
ago (otherwise, cancer = 0); diameter is the 
diameter of the nodule in mm; spiculation = 1 
if the edge of the nodule has spicules (otherwise, 
Introduction
Pulmonary nodules have always represented 
a major diagnostic challenge, which is cause for 
justified concern given the incidence of malignant 
(metastatic or primary) lung tumors. In recent 
decades, there has been an increase in the incidence 
of, and consequently, in the mortality from, 
primary lung cancer, concomitantly with advances 
in imaging techniques, which have resulted in 
increased detection of pulmonary nodules. In 
this context, the finding of a solitary pulmonary 
nodule (SPN) has become crucial for the early 
detection of primary lung cancer, which, according 
to data from the Brazilian National Ministry of 
Health Mortality Database, is the leading cause 
of cancer death, surpassing the number of deaths 
from prostate and breast cancer when gender 
is not taken into account.
An SPN is defined as a more or less spherical 
lung opacity that is less than 3 cm in diameter. It 
usually has well-defined margins, is completely 
surrounded by lung parenchyma, and is without 
other radiological abnormalities, such as atelectasis 
and mediastinal lymph node enlargement.(1,2)
Several ways to estimate the malignant 
potential of SPNs have been devised. Among 
the most widespread are two mathematical 
models based on multivariate analysis of the 
clinical characteristics of patients with SPNs 
and the radiological characteristics of SPNs, 
one of which was published by Swensen et al.
(3) in 1997 and one of which was published by 
Gould et al.(4) in 2007. In those two studies, the 
authors developed mathematical formulas to 
calculate the probability of SPN malignancy with 
the purpose of providing guidance for attending 
physicians, the probabilistic models having been 
extensively tested and approved, especially in 
populations in the USA and Europe.(3-5) In a study 
conducted in the Philippines, the high prevalence 
of tuberculosis made it impossible to repeat that 
finding, demonstrating the ineffectiveness of 
the models for that population.(6)
Since, to date, there have been no studies 
in Brazil aimed at evaluating these models 
in a population in the country, the objective 
of the present study was to analyze clinical 
and radiological variables that influence the 
pathological diagnosis of SPN and to compare and 
validate the two aforementioned mathematical 
models(3,4) for calculating the probability of SPN 
malignancy in patients with SPN in Brazil.
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Diagnostic performance and the best 
cut-off point for both mathematical models 
were determined by analysis of the ROC and 
two-graph ROC curves.(8) For the cut-off points, 
we calculated the sensitivity, specificity, accuracy, 
negative predictive value, and positive predictive 
value of the models. We also calculated the area 
under the curve and compared the models.
Results
We evaluated 110 patients. Of those, 59 were 
male and 51 were female. We found no significant 
association between gender and the diagnosis of 
SPN malignancy. The same was true for presence 
of comorbidities, history of malignancy prior 
to the diagnosis of SPN, and smoking status. 
Neither the number of years since smoking 
cessation nor smoking history in pack-years had 
any influence on the pathological diagnosis of 
SPN. The only clinical characteristic that was 
significantly associated with SPN malignancy 
was age (p = 0.006), when it was stratified into 
groups, with increasing ORs, culminating in an 
OR of 5.70 for the > 70 year age group (Table 1).
Among the radiological characteristics, presence 
of spiculated margins (p = 0.001) and lesion 
diameter (p = 0.001) were significantly associated 
spiculation = 0); and location = 1 if the nodule is 
located in an upper lobe (otherwise, location = 0).
Equations developed by Gould et al.(4):
Probability of malignant SPN = ex/(1+ ex) (1)
x = −8.404 + (0.779 × age) +  
+ (2.061 × smoke) + (0.112 × diameter) −  
− (0.567 × Y)  
(3)
where age is age in years; smoke is 1 if a current 
or former smoker (otherwise 0); diameter is the 
largest diameter of the nodule in mm; and Y 
is the number of years since quitting smoking 
divided by 10.
For the statistical analysis, we used the 
Statistical Package for the Social Sciences, version 
13.0 for Windows (SPSS Inc., Chicago, IL, USA), 
and the Statistical Package for the Social Sciences, 
version 20.0 for Mac. We also used BioEstat, 
version 5.0 for Windows, for complementary 
analyses and for constructing the ROC curves.
In order to determine possible differences 
among the groups studied, we used the Student’s 
t-test for parametric variables, Pearson’s chi-square 
test for nonparametric variables, and Fisher’s exact 
test for dichotomous variables.(7) The level of 
significance was set at 5% for all statistical tests.
Table 1 - Clinical characteristics of the patients and radiological characteristics of the solitary pulmonary 
nodules.
Characteristic
SPN malignancy
p ORNo Yes
% %
Male gender 55.93 44.07 0.18
Age bracket, years
21-50 40.00 16.36 0.006 1.00
51-60 18.18 23.67 3.18
61-70 30.91 34.54 2.73
> 70 10.91 25.45 5.70
Presence of comorbidities 49.12 50.88 0.85
History of malignancy 35 65 0.14
Ever smoking 46.91 53.09 0.28
Time since smoking cessation (former smokers), years 8.58 ± 11.98a 10.12 ± 7.67a 0.09
Smoking history, pack-years 48.51 ± 28.44a 50.15 ± 35.12a 0.82
SPNs in the ULs 51.78 48.21 0.70
Presence of spiculated margins 33.34 66.66 0.001
SPN diameter, mm 15.87 ± 7.37a 20.60 ± 6.69a
≤ 10 34.55 21.82 0.001 1.00
10.1-20.0 43.64 41.82 1.52
> 20,1 21.81 36.36 2.64
SPN: solitary pulmonary nodule; and UL: upper lobe. aValues expressed as mean ± SD.
562 Melo CBC, Perfeito JAJ, Daud DF, Costa Júnior ASC, Santoro IL, Leão LEV
J Bras Pneumol. 2012;38(5):559-565
to establish a definitive pathological diagnosis 
and identified three independent risk factors 
for SPN malignancy: advanced age; presence 
with SPN malignancy. Stratification of this analysis 
by lesion diameter revealed increasing ORs, with 
SPNs of 20.1-30 mm in diameter reaching an 
OR of 2.64 (Table 1).
After calculating the probability of SPN 
malignancy with the mathematical model of 
Swensen et al.,(3) we constructed a ROC curve, 
the area under the ROC curve (AUC) being 
0.79 ± 0.44 (95% CI: 0.70-0.88; Figure 1). The 
construction of a two-graph ROC curve allowed 
us to determine an optimal cut-off point in 
relation to the various cut-off points along the 
ROC curve (Figure 2), with higher sensitivity and 
specificity being obtained below 15% or above 
66.5% (a yield higher than 95%; Table 2).
For the model of Gould et al.,(4) we obtained 
an AUC of 0.69 ± 0.50 (95% CI: 0.59-0.79; 
Figure 3). By analyzing the two-graph ROC curve, 
we observed the behavior of the various cut-off 
points in relation to sensitivity and specificity; 
for a maximum yield (greater than 95%), the 
calculated cut-off points were below 8.5% and 
above 82.3% (Table 2).
Discussion
The diagnosis of SPN remains a major 
challenge in medical practice. In the present 
study, we evaluated a sample of patients who 
had undergone surgical resection of SPN in order 
Figure 1 - ROC curve comparing the models of 
Swensen et al.(3) and Gould et al.(4) #A: ROC curve 
for the probabilistic model of Swensen et al.,(3) with 
an area under the curve (AUC) of 0.79 ± 0.44 (95% 
CI: 0.70-0.88); #B: ROC curve for the probabilistic 
model of Gould et al.,(4) with an AUC of 0.69 ± 0.50 
(95% CI: 0.59-0.79); and d: distance to the leftmost 
point of the ROC curve (d = 0.39) of the model of 
Swensen et al.(3)
Figure 2 - Two-graph ROC curve for the probabilistic 
model for predicting malignancy of Swensen et al.(3) 
in our sample.
Figure 3 - Two-graph ROC curve for the probabilistic 
model for predicting malignancy of Gould et al.(4) in 
our sample.
Table 2 - Values derived from the two-graph ROC 
curve for the cut-off points determined in the analysis 
of the mathematical models of Swensen et al.(3) and 
Gould et al.(4)
Statistical analysis
Modelsa
Swensen et al. Gould et al.
Cut-off point 37.00 40.81
Sensitivity 71.40 65.50
Specificity 72.50 67.30
Positive predictive value 71.38 66.70
Negative predictive value 72.52 66.11
Accuracy of the test 71.96 66.40
aValues expressed as %.
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that the AUC found in the present study 
(0.79 ± 0.44; 95% CI: 0.70-0.88) was nearly 
identical to the values reported by other groups 
of researchers, who validated both probabilistic 
models in similar studies.(16,17) This AUC allows us 
to state that the aforementioned mathematical 
model showed good accuracy (AUC > 0.70), which 
supports the use of that model as a diagnostic 
test, as has been proposed.(18) By analyzing the 
ROC and two-graph ROC curves, we observed 
the behavior of the various cut-off points: the 
values at the ends of the curves, i.e., the cut-off 
points below 15.0% and above 66.5%, are the 
values with the highest yield, a sensitivity of 
95.9% and a specificity of 35.3% having been 
found for the cut-off points below 15.0% 
and a sensitivity of 36.7% and a specificity of 
94.1% having been found for the cut-off points 
above 66.5%. In brief, in patients for whom the 
probability of malignancy was ≤ 15.0%, the rates 
of true positives were so high (showed such a 
high sensitivity) that, in theory, they would have 
allowed us to withhold treatment in our sample, 
whereas, in patients for whom the probability of 
malignancy was ≤ 11.0%, sensitivity was 100%, 
this being therefore the lowest possible rate of 
false negatives. At the other end of the curve, 
we found patients for whom the probability 
of malignancy was ≥ 66.5%; at this cut-off 
point, sensitivity was 36.7% and specificity 
was 94.1%, i.e., they reached values that allow 
referral for surgical resection of SPN because 
of a high diagnostic rate, which increases after 
that percentile, reaching a specificity of 100% 
above the cut-off point of 80.5% (i.e., minimizing 
the occurrence of false negatives). For patients 
with intermediate probability of malignancy (i.e., 
those for whom the probability was between 
15.0% and 66.5%), the model was found to 
be ineffective in predicting the probability of 
SPN malignancy, being therefore an unreliable 
diagnostic test. For such patients, further tests, 
including positron emission tomography and 
biopsy (transbronchial or transthoracic biopsy), 
are necessary.
For the model of Gould et al.,(4) our analysis 
of the ROC curve revealed an AUC of 0.69 ± 0.50 
(95% CI: 0.59-0.79) and an accuracy of 66.40%. 
Reliable cut-off points were obtained only with 
values ≤ 8.36% (sensitivity of 94.4% and specificity 
of 21.4%) and values ≥ 82.3% (sensitivity of 
13.0% and specificity of 94.6%). Therefore, for 
of spiculated margins; and SPN diameter. The 
other clinical and radiological characteristics of 
the patients with SPN showed no significant 
associations with SPN malignancy in our sample.
In several recent studies, age has been 
reported to be one of the major risk factors 
for SPN malignancy.(3,4,9,10) Stratification by age 
revealed a statistically significant association 
between age and malignancy, as well as increasing 
ORs. This finding corroborates current findings 
demonstrating that older individuals, especially 
those over 50 years of age, are at a higher risk 
for malignant SPN.
Spiculated (corona radiata) margins are 
predictive of SPN malignancy, the positive 
predictive value being as high as 94%, whereas 
lobulated margins have a positive predictive value 
for malignancy of up to 80%.(11-13) This was also 
true in the present study, in which we found 
that two thirds of the malignant lesions had 
irregular, spiculated edges or irregular, lobulated 
edges, a finding that was statistically significant 
(p = 0.001).
The mean lesion diameter is also an important 
risk factor for malignancy, especially when it 
increases and approaches 30 mm. Numerous studies 
have confirmed this finding, always associating 
lesion growth with its malignant potential. 
Nodules of more than 20 mm in diameter have 
a greater than 50% chance of being diagnosed 
as malignant.(14,15) This is consistent with the 
findings of the present study, in which we found 
a significant association between lesion diameter 
and malignancy when we compared the mean 
lesion diameters among the stratified groups, 
stratification having revealed increasing ORs.
We also evaluated two mathematical models 
for predicting the likelihood of SPN malignancy. 
Although both models are widely disseminated, 
we found no studies investigating either model 
in a population in Brazil. One group of authors 
recently tested the model of Swensen et al.(3) in a 
population in the Philippines and found that the 
model was not valid as a predictor of malignancy, 
a finding that was associated with the high rate 
of tuberculosis in the study population.(6) In our 
study population, both models proved effective in 
predicting the malignant potential of SPNs, the 
model of Swensen et al.(3) being more accurate 
than that of Gould et al.(4)
The results obtained with the use of the 
equations developed by Swensen et al.(3) showed 
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cases within the range between these cut-off 
points, it is impossible to draw reliable conclusions 
based on the model, and further investigation 
being therefore necessary.
For our sample, we found that the mathematical 
model of Swensen et al.(3) was superior to that of 
Gould et al;(4) through analysis of superimposed 
ROC curves, we observed a greater AUC for the 
former, as well as a narrower range between the 
reliable cut-off points. This behavior demonstrated 
that, in our sample, the mathematical model 
proposed by Swensen et al.(3) had a higher 
diagnostic accuracy. Recently, in a study conducted 
in the USA, the two models were compared and 
were found to have very similar behaviors,(16) a 
finding that is in disagreement with ours.
In conclusion, of the clinical and radiological 
characteristics related to SPNs, three showed 
a statistically significant association with SPN 
malignancy: advanced age; presence of spiculated 
margins on chest CT; and greater maximum 
SPN diameter.
By comparing the model of Swensen et al.(3) 
and that of Gould et al.,(4) we found that the 
former had a higher yield, with higher sensitivity, 
specificity, and accuracy.
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